Delivery Order SPE2DB22D3009-SPE2DB26FAH01
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,545.62 to supply Eucrisa 2% Ointment in 100-gram quantities. This non-competitive, competitively awarded delivery order represents a firm fixed price contract with an ultimate completion date of June 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is a child order issued under a larger Indefinite Delivery Contract vehicle. This...
- The Defense Logistics Agency awarded a $11,317.58 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Eucrisa 2% Ointment in 60-gram units. The contract is non-competitive and carries an ultimate completion date of September 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Eucrisa 2% Ointment in 60-gram quantities, with a ceiling value of $1,688.16. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. The delivery order is issued under AmerisourceBergen's...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company, to provide a specialty branded pharmaceutical product - Eucrisa 2% Ointment 60GM. The award, valued at $7,349.06, has an ultimate completion date of March 28, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, serves as...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,991.09 contract is for the delivery of Eucrisa 2% ointment, a prescription skin treatment medication, with a completion date of December 7, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,777.97 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Eucrisa 2% ointment, a topical medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,790.85 to AmerisourceBergen Drug Corp for EUCRISA 2% Ointment (60 gm) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. EUCRISA is a topical calcineurin inhibitor commonly used to treat atopic dermatitis and other inflammatory skin...
- The Defense Logistics Agency Troop Support Medical awarded a $650.15 firm fixed price delivery order to Amerisourcebergen Drug Corp for 100 grams of EUCRISA 2% ointment. Amerisourcebergen Drug Corp will deliver the ointment to a location in Conshohocken, Pennsylvania under the single day contract running from August 10th to August 11th, 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, this order for a topical medication supports the Defense...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the topical ointment medication Eucrisa (crisaborole) 2% in 60-gram units. The $3,673.74 firm-fixed-price contract has a completion date of February 15, 2023 and does not include any set-aside requirements, indicating open competition. AmerisourceBergen is the prime contractor for this delivery order, which is a part of the company's...
- The federal contract award is for the delivery of Eucrisa 2% ointment, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,384.68 firm fixed-price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is a part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC serves as a primary...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB26FAH01Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,670.68 to AmerisourceBergen Drug Corp for the supply of Eucrisa 2% Ointment (60 grams), a topical medication commonly used for dermatological treatments. This non-competitive delivery order, issued on October 31, 2025, represents a firm fixed-price transaction with an ultimate completion date of November 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs across the Defense Health Agency and other government healthcare systems. The company's extensive contract portfolio with the DLA demonstrates its capability to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains, from specialty medications and vaccines to medical devices and generic drugs. This delivery order exemplifies the operational flexibility and scale of AmerisourceBergen's federal contracting relationship, enabling rapid fulfillment of specific medical commodity requirements for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 10/31/25 |